LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Geron Corp

Chiusa

SettoreSettore sanitario

1.45

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.43

Massimo

1.45

Metriche Chiave

By Trading Economics

Entrata

3.5M

-16M

Vendite

9.4M

49M

Margine di Profitto

-33.394

Dipendenti

229

EBITDA

9.2M

-7.6M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+97.24% upside

Dividendi

By Dow Jones

Utili prossimi

6 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

97M

868M

Apertura precedente

1.45

Chiusura precedente

1.45

Notizie sul Sentiment di mercato

By Acuity

45%

55%

143 / 374 Classifica in Healthcare

Geron Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 ago 2025, 16:11 UTC

I principali Market Mover

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

15 ago 2025, 22:22 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

15 ago 2025, 22:22 UTC

Discorsi di Mercato

Target Is Falling Behind Its Peers -- Market Talk

15 ago 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

15 ago 2025, 20:33 UTC

Discorsi di Mercato

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

15 ago 2025, 20:25 UTC

Utili
Acquisizioni, Fusioni, Takeovers

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

15 ago 2025, 20:24 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 ago 2025, 20:18 UTC

Utili

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 ago 2025, 19:14 UTC

Discorsi di Mercato

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

15 ago 2025, 19:12 UTC

Discorsi di Mercato

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

15 ago 2025, 18:32 UTC

Discorsi di Mercato

Coffee Futures Surge on New Brazilian Frost -- Market Talk

15 ago 2025, 17:33 UTC

Discorsi di Mercato

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

15 ago 2025, 17:23 UTC

Discorsi di Mercato
Utili

Deere's Earnings Appear to Be Troughing -- Market Talk

15 ago 2025, 16:27 UTC

Utili

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

15 ago 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

15 ago 2025, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 ago 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

15 ago 2025, 16:05 UTC

Acquisizioni, Fusioni, Takeovers

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

15 ago 2025, 15:52 UTC

Acquisizioni, Fusioni, Takeovers

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

15 ago 2025, 15:36 UTC

Discorsi di Mercato

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

15 ago 2025, 15:29 UTC

Utili

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 ago 2025, 15:29 UTC

Acquisizioni, Fusioni, Takeovers

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 ago 2025, 15:28 UTC

Utili

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

15 ago 2025, 15:24 UTC

Discorsi di Mercato

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

15 ago 2025, 15:08 UTC

Discorsi di Mercato

Applied Materials Is Losing Share in Chips Business -- Market Talk

15 ago 2025, 14:38 UTC

Acquisizioni, Fusioni, Takeovers

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

15 ago 2025, 14:37 UTC

Acquisizioni, Fusioni, Takeovers

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

15 ago 2025, 14:37 UTC

Acquisizioni, Fusioni, Takeovers

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

15 ago 2025, 14:36 UTC

Acquisizioni, Fusioni, Takeovers

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

15 ago 2025, 14:33 UTC

Acquisizioni, Fusioni, Takeovers

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Confronto tra pari

Modifica del prezzo

Geron Corp Previsione

Obiettivo di Prezzo

By TipRanks

97.24% in crescita

Previsioni per 12 mesi

Media 2.86 USD  97.24%

Alto 5 USD

Basso 1 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Geron Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

8 ratings

4

Acquista

3

Mantieni

1

Vendi

Sentiment

By Acuity

143 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.